ZhihongZhongMD

PubMed

• A phase 1b, open-label study of trebananib in combination with paclitaxel and carboplatin in patients with ovarian cancer receiving interval or primary debulking surgery.
  Vergote, I.,Oaknin, A.,Baurain, J. F.,Ananda, S.,Wong, S.,Su, X.,Wu, B.,Zhong, Z.,Warner, D.,Casado, A.> ;Eur. J. Cancer. 2014 Jul 20
• Improvements in health-related quality of life with belimumab, a B-lymphocyte stimulator-specific inhibitor, in patients with autoantibody-positive systemic lupus eryt...
  Strand, V.,Levy, R. A.,Cervera, R.,Petri, M. A.,Birch, H.,Freimuth, W. W.,Zhong, Z. J.,Clarke, A. E.> ;Ann. Rheum. Dis.. 2013 Mar 26
• 118 citations
  Disease Control and Safety of Belimumab Plus Standard Therapy Over 7 Years in Patients with Systemic Lupus Erythematosus
  Ellen M. Ginzler, Daniel J. Wallace, Joan T. Merrill, Richard Furie, William Stohl, W. Winn Chatham, Arthur Weinstein, James D. McKay, W. Joseph McCune, Z. John Zhong,...> ;The Journal of Rheumatology. 2014 Feb 1
• Efficacy and safety of belimumab in patients with rheumatoid arthritis: a phase II, randomized, double-blind, placebo-controlled, dose-ranging Study.
  Stohl W, Merrill JT, McKay JD, Lisse JR, Zhong ZJ, Freimuth WW, Genovese MC> ;J. Rheumatol.. 2013-05-01
• Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: co...
  Manzi S, Sánchez-Guerrero J, Merrill JT, Furie R, Gladman D, Navarra SV, Ginzler EM, D'Cruz DP, Doria A, Cooper S, Zhong ZJ, Hough D, Freimuth W, Petri MA> ;Ann. Rheum. Dis.. 2012-11-01
• Effect of belimumab on vaccine antigen antibodies to influenza, pneumococcal, and tetanus vaccines in patients with systemic lupus erythematosus in the BLISS-76 trial.
  Chatham WW, Wallace DJ, Stohl W, Latinis KM, Manzi S, McCune WJ, Tegzová D, McKay JD, Avila-Armengol HE, Utset TO, Zhong ZJ, Hough DR, Freimuth WW, Migone T> ;J. Rheumatol.. 2012-08-01
• Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response.
  van Vollenhoven RF, Petri MA, Cervera R, Roth DA, Ji BN, Kleoudis CS, Zhong ZJ, Freimuth W> ;Ann. Rheum. Dis.. 2012-08-01
• Clinical, laboratory and health-related quality of life correlates of Systemic Lupus Erythematosus Responder Index response: a post hoc analysis of the phase 3 belimum...
  Furie, R.,Petri, M. A.,Strand, V.,Gladman, D. D.,Zhong, Z. J.,Freimuth, W. W.> ;Lupus Sci Med. 2014 Nov 15
• Join now to see all